Patent Open Access

An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants

Alkoclar, Erdal Can; Yesil, Metehan

A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.

 

Inventors: Erdal Can Alkoclar & Metehan Yesil

Files (77.3 kB)
Name Size
edd4184f-a69b-4f51-ba23-5b6a2a63b260 4.pdf
md5:c1ba22cf6e020b70236675a153c65af2
77.3 kB Download
0
0
views
downloads
All versions This version
Views 00
Downloads 00
Data volume 0 Bytes0 Bytes
Unique views 00
Unique downloads 00

Share

Cite as